Insta
Serum Institute of India (Pic Via Twitter)
In a positive development for India's fight against the Covid-19 pandemic, millions of doses of the Covishield vaccine, which is being manufactured by the Pune based Serum Institute of India (SII), have passed the quality test at the government's laboratory for testing vaccines, reports Economic Times.
As many as 25 million doses of the Covishield vaccine are said to have been tested for quality at the Kasauli based Central Drug Laboratory (CDL). Now, these doses can be rolled out for administration as soon as Covishield is approved and cleared by the Drugs Controller General of India (DCGI).
Covishield vaccine has been developed by the University of Oxford in association with pharmaceutical major AstraZeneca. The said vaccine is currently undergoing Phase-III clinical trials in India and SII has already applied for an emergency use authorisation (EUA) of the same.
Led by Adar Poonawalla, SII, which is the world's largest vaccine manufacturer in term of doses, has already begun stockpiling doses of Covishield which can be rolled out once it is approved for administration in the nation. Recently, Prime Minister (PM) Narendra Modi had also visited the company's campus in Pune to review the progress of vaccine development.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest